AbbVie extends slide to a seventh straight session
Seeking Alpha ·
AbbVie ( ABBV ) declines 1.30% to $244.78 in Tuesday afternoon trading, on track for its seventh straight session of losses. Over the past six trading sessions, the stock has declined 5.1%, compared with a 0.44% gain for the broader S&P 500 index. Year to date, AbbVie
AI 시장 분석
AbbVie stock fell for the seventh consecutive session, closing down 1.30% at $244.78. While the stock has declined 5.1% over the last six trading days, the S&P 500 rose 0.44% during the same period, indicating underperformance relative to the broader market. Investors are concerned about the breakdown of technical support levels and potential dampening of sentiment across the pharmaceutical sector.
하락 영향
- Biotech — AbbVie's seven-day losing streak is negatively impacting sentiment across the broader pharmaceutical and biotech sectors. Weakness in major pharma stocks risks accelerating capital outflows and increasing near-term volatility.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 40% · Bearish (Short) 60%
257 participants